These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4727354)
1. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). 3. Absorption, distribution and excretion of D- and L-DOPA-14C in rats following intravenous and oral administration. Shindo H; Nakajima E; Kawai K; Miyakoshi N; Tanaka K Chem Pharm Bull (Tokyo); 1973 Apr; 21(4):817-25. PubMed ID: 4727354 [No Abstract] [Full Text] [Related]
2. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). IV. Urinary and tissue metabolites of D- and L-DOPA-14C after intravenous and oral administration to rats. Shindo H; Komai T; Tanaka K; Nakajima E; Miyakoshi N Chem Pharm Bull (Tokyo); 1973 Apr; 21(4):826-36. PubMed ID: 4727355 [No Abstract] [Full Text] [Related]
3. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). V. Mechanism of intestinal absorption of D- and L-DOPA-14C in rats. Shindo H; Komai T; Kawai K Chem Pharm Bull (Tokyo); 1973 Sep; 21(9):2031-8. PubMed ID: 4785106 [No Abstract] [Full Text] [Related]
4. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats. Rivera-Calimlim L Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764 [TBL] [Abstract][Full Text] [Related]
5. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). II. Autoradiographic study on the distribution of 14 C-labeled D- and L-DOPA after oral administration in rats. Shindo H; Miyakoshi N; Nakajima E Chem Pharm Bull (Tokyo); 1972 May; 20(5):966-73. PubMed ID: 5055126 [No Abstract] [Full Text] [Related]
6. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). I. Autoradiographic study on the distribution of 14 C-labeled D- and L-DOPA and dopamine after intravenous administration in rats. Shindo H; Miyakoshi N; Takahashi I Chem Pharm Bull (Tokyo); 1971 Dec; 19(12):2490-500. PubMed ID: 5145918 [No Abstract] [Full Text] [Related]
7. Kinetics of absorption and excretion of levodopa in dogs. Coutinho CB; Spiegel HE; Kaplan SA; Yu M; Christian RP; Carbone JJ; Symington J; Cheripko JA; Lewis M; Tonchen A; Crews T J Pharm Sci; 1971 Jul; 60(7):1014-8. PubMed ID: 5115239 [No Abstract] [Full Text] [Related]
8. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). VI. Metabolism of D-DOPA in rat kidney. Shindo H; Maeda T Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1721-31. PubMed ID: 4154147 [No Abstract] [Full Text] [Related]
9. Decarboxylation of orally administered L-dopa in the human digestive tract. Bergmark J; Carlsson A; Granerus AK; Jagenburg R; Magnusson T; Svanborg A Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(4):437-40. PubMed ID: 4260263 [No Abstract] [Full Text] [Related]
10. [The absorption, distribution and excretion of 14 C-L-DOPA in the mouse and uptake into the cat corpus striatum]. Yoshikawa M; Sato Y Yakugaku Zasshi; 1972 May; 92(5):551-64. PubMed ID: 5066310 [No Abstract] [Full Text] [Related]
11. Effect of intravenous and oral administration of L-dopa on HGH and TSH release. Yoshimura M; Ochi Y; Miyazaki T; Shiomi K; Hachiya T Endocrinol Jpn; 1972 Dec; 19(6):543-8. PubMed ID: 4679232 [No Abstract] [Full Text] [Related]
12. Distribution of DOPA-2- 14 C in relation to DOPA-1- 14 C (carboxyl- 14 C-labelled DOPA) in mice before and after inhibition of DOPA-decarboxylase, studied by whole-body autoradiography. Tjälve H; Ullberg S Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):376-88. PubMed ID: 4627124 [No Abstract] [Full Text] [Related]
13. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography. Imai K; Sugiura M; Kubo H; Tamura Z; Oya K Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616 [No Abstract] [Full Text] [Related]
14. The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study. Horne MK; Cheng CH; Wooten GF Pharmacology; 1984; 28(1):12-26. PubMed ID: 6701184 [TBL] [Abstract][Full Text] [Related]
15. Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease. Granerus AK; Jagenburg R; Svanborg A Naunyn Schmiedebergs Arch Pharmacol; 1973; 280(4):429-39. PubMed ID: 4274706 [No Abstract] [Full Text] [Related]
16. Absorption and metabolism of L-dopa by the human stomach. Rivera-Calimlim L; Dujovne CA; Morgan JP; Lasagna L; Bianchine JR Eur J Clin Invest; 1971 May; 1(5):313-20. PubMed ID: 5558777 [No Abstract] [Full Text] [Related]
17. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa. Bianchine JR; Messiha FS; Hsu TH Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372 [No Abstract] [Full Text] [Related]
18. The conversion of exogenously administered L-DOPA to dopamine in the stomach and liver of rats. Osumi Y; Wada I; Fujiwara M Jpn J Pharmacol; 1972 Oct; 22(5):723-6. PubMed ID: 4539790 [No Abstract] [Full Text] [Related]
19. The use of isolated perfused rat brains in a study of 14C-L-DOPA metabolism. Horst WD; Jester J Life Sci I; 1971 Jun; 10(12):685-9. PubMed ID: 5104924 [No Abstract] [Full Text] [Related]
20. Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa. Rivera-Calimlim L Br J Pharmacol; 1972 Dec; 46(4):708-13. PubMed ID: 4655269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]